Breaking News Instant updates and real-time market news.

GBT

Global Blood Therapeutics

$53.58

-3.87 (-6.74%)

12:25
06/14/19
06/14
12:25
06/14/19
12:25

Global Blood Therapeutics to hold a conference call

Management provides an update on the Phase 3 HOPE Trial as presented at the 24th Congress of EHA, on a conference call to be held on June 14 at 1 pm. Webcast Link

  • 14

    Jun

  • 18

    Jun

GBT Global Blood Therapeutics
$53.58

-3.87 (-6.74%)

06/14/19
HCWC
06/14/19
NO CHANGE
Target $150
HCWC
Buy
Global Blood a 'logical bolt on acquisition candidate,' says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay believes the data this morning from Global Blood Therapeutics "continues to de-risk the story." He believes the package for voxelotor supports accelerated approval and that Global Blood is now a "logical bolt on acquisition candidate for one of the large hematology-centric franchises." He reiterates a Buy rating on the shares with a $150 price target. Chattopadhyay says that while the Street remains fixated on a lack of statistically significant benefit in vaso-occlusive crises from a study "that was not powered for such," he defers to the October 2018 FDA workshop directed at preventing end-organ damage by lowering hemolysis as a "marked evolution in the thought process at the agency."
06/14/19
CANT
06/14/19
NO CHANGE
Target $110
CANT
Overweight
Global Blood price target raised to $110 from $96 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for Global Blood Therapeutics to $110 from $96 saying the Hope trial indicates "disease-modifying potential" of voxelotor in sickle cell disease. The analyst reiterates an Overweight rating on the shares. Global Blood in premarket trading is down 6%, or $3.22, to $54.30.
06/14/19
WELS
06/14/19
NO CHANGE
WELS
Outperform
Global Blood Therapeutics data should support 'rapid approval,' says Wells Fargo
Wells Fargo analyst Jim Birchenough reiterates an Outperform rating on Global Blood Therapeutics following release of the final Hope Phase 3 results for hemoglobin modifier voxelotor in sickle cell disease. The analyst expects the data to support "rapid approval and commercial success" in sickle cell. He notes that no patient discontinued due to an adverse event with the exception of a single patient in the placebo group.
06/03/19
WEDB
06/03/19
NO CHANGE
Target $107
WEDB
Outperform
Global Blood Therapeutics price target raised to $107 from $95 at Wedbush
Wedbush analyst Liana Moussatos raised her price target for Global Blood Therapeutics to $107 from $95 given reduced clinical, regulatory, commercial and manufacturing risk along with sufficient cash for initial U.S. launch, strong IP and upside potential from multiple potentially material catalysts and as more investors appreciate that FDA is not solely focused on VOC as a primary endpoint for SCD. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

, GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

18:09
06/24/19
06/24
18:09
06/24/19
18:09
Periodicals
Google tells workers Pride protests are against code of conduct, Verge says »

According to internal…

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

AAPL

Apple

$198.60

-0.17 (-0.09%)

17:53
06/24/19
06/24
17:53
06/24/19
17:53
Hot Stocks
Apple to add 2,000 employees in Seattle over next 5 years »

Seattle mayor Jenny A.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$111.25

0.08 (0.07%)

, FB

Facebook

$192.56

1.4 (0.73%)

17:51
06/24/19
06/24
17:51
06/24/19
17:51
Periodicals
Walmart in Mexico rolls out grocery delivery via WhatsApp, Reuters says »

Walmart's (WMT)…

WMT

Walmart

$111.25

0.08 (0.07%)

FB

Facebook

$192.56

1.4 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

  • 15

    Aug

  • 13

    Nov

CAT

Caterpillar

$134.37

0.43 (0.32%)

17:46
06/24/19
06/24
17:46
06/24/19
17:46
Hot Stocks
Caterpillar awarded share of $900M Defense Logistics Agency contract »

Caterpillar is sharing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$35.14

0.06 (0.17%)

17:45
06/24/19
06/24
17:45
06/24/19
17:45
Hot Stocks
FB Financial provides update on its exit of wholesale mortgage channels »

FB Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$31.11

-0.99 (-3.08%)

17:44
06/24/19
06/24
17:44
06/24/19
17:44
Hot Stocks
Fluor: Stork consortium awarded four-year agreement by Ecopetrol in Colombia »

Fluor announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERYP

Erytech Pharma

$6.69

(0.00%)

17:33
06/24/19
06/24
17:33
06/24/19
17:33
Hot Stocks
Erytech Pharma announces strategic collaboration with SQZ Biotechnologies »

ERYTECH Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

17:33
06/24/19
06/24
17:33
06/24/19
17:33
Hot Stocks
Lockheed Martin awarded $561.80M Army contract »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$35.38

-1.01 (-2.78%)

17:30
06/24/19
06/24
17:30
06/24/19
17:30
Syndicate
The Medicines Co. files to sell $150M of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHTLY

Metcash

$0.00

(0.00%)

17:30
06/24/19
06/24
17:30
06/24/19
17:30
Downgrade
Metcash rating change at Goldman Sachs »

Metcash downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

, LLL

L3 Technologies

$256.30

(0.00%)

17:28
06/24/19
06/24
17:28
06/24/19
17:28
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

LLL

L3 Technologies

$256.30

(0.00%)

AAXN

Axon

$73.22

-0.12 (-0.16%)

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

HRS

Harris

$197.28

-0.07 (-0.04%)

USNA

Usana

$72.41

-0.58 (-0.79%)

LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

ABCB

Ameris Bancorp

$37.76

(0.00%)

XNCR

Xencor

$33.86

-1.31 (-3.72%)

HF

HFF Inc.

$45.25

-0.29 (-0.64%)

JLL

Jones Lang LaSalle

$137.43

-2.075 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 06

    Aug

  • 26

    Aug

TMSR

TMSR Holding

$1.67

(0.00%)

17:28
06/24/19
06/24
17:28
06/24/19
17:28
Syndicate
Breaking Syndicate news story on TMSR Holding »

TMSR Holding files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$35.38

-1.01 (-2.78%)

17:27
06/24/19
06/24
17:27
06/24/19
17:27
Syndicate
Breaking Syndicate news story on The Medicines Co. »

The Medicines Co. files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XNCR

Xencor

$33.86

-1.31 (-3.72%)

, HF

HFF Inc.

$45.25

-0.29 (-0.64%)

17:22
06/24/19
06/24
17:22
06/24/19
17:22
Hot Stocks
Xencor to replace HFF Inc. in S&P 600 at open on 7/2 »

Jones Lang LaSalle (JLL)…

XNCR

Xencor

$33.86

-1.31 (-3.72%)

HF

HFF Inc.

$45.25

-0.29 (-0.64%)

JLL

Jones Lang LaSalle

$137.43

-2.075 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 06

    Aug

  • 26

    Aug

USNA

Usana

$72.41

-0.58 (-0.79%)

, LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

17:20
06/24/19
06/24
17:20
06/24/19
17:20
Hot Stocks
Usana to replace Fidelity Southern in S&P 600 at open on 7/1 »

Ameris Bancorp (ABCB) is…

USNA

Usana

$72.41

-0.58 (-0.79%)

LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

ABCB

Ameris Bancorp

$37.76

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

, AAXN

Axon

$73.22

-0.12 (-0.16%)

17:19
06/24/19
06/24
17:19
06/24/19
17:19
Hot Stocks
Breaking Hot Stocks news story on Mesa Labs, Axon »

Mesa Labs to replace Axon…

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

AAXN

Axon

$73.22

-0.12 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAXN

Axon

$73.22

-0.12 (-0.16%)

, MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

17:18
06/24/19
06/24
17:18
06/24/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Axon, MarketAxess »

Axon to replace…

AAXN

Axon

$73.22

-0.12 (-0.16%)

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

, LLL

L3 Technologies

$256.30

(0.00%)

17:18
06/24/19
06/24
17:18
06/24/19
17:18
Hot Stocks
MarketAxess to replace L3 Technologies in S&P 500 at open on 7/1 »

Harris (HRS) is acquiring…

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

LLL

L3 Technologies

$256.30

(0.00%)

HRS

Harris

$197.28

-0.07 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGZ

Vista Gold

$0.81

-0.0026 (-0.32%)

17:04
06/24/19
06/24
17:04
06/24/19
17:04
Hot Stocks
Vista Gold CFO Jack Engele to retire, Douglas Tobler to succeed »

Vista Gold is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$198.60

-0.17 (-0.09%)

17:03
06/24/19
06/24
17:03
06/24/19
17:03
Periodicals
Apple to announce Seattle expansion on Monday, Seattle Times reports »

According to a story by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$15.00

0.07 (0.47%)

, CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Hot Stocks
HP Enterprise appoints Crowdstrike CEO George Kurtz to Board of Directors »

Hewlett Packard…

HPE

HP Enterprise

$15.00

0.07 (0.47%)

CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

NGM

NGM Biopharmaceuticals

$13.88

0.1 (0.73%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Initiation
NGM Biopharmaceuticals initiated at Stifel »

NGM Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$13.81

-0.27 (-1.92%)

17:00
06/24/19
06/24
17:00
06/24/19
17:00
Hot Stocks
Armistice Capital reports 6.2% passive stake in Vanda Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

CBAY

CymaBay

$6.76

-0.32 (-4.52%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Initiation
CymaBay initiated at Stifel »

CymaBay initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

$27.47

-0.73 (-2.59%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Hot Stocks
Park Hotels & Resorts announces sale of three non-core assets for $166M »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.